Lantern Pharma, Inc. (LTRN)
1.62
+0.20
(+14.08%)
USD |
NASDAQ |
Apr 02, 16:00
1.56
-0.06
(-3.70%)
After-Hours: 20:00
Lantern Pharma EPS Diluted (Quarterly) : -0.362 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.651 |
| BioVie, Inc. | -0.7663 |
| Acurx Pharmaceuticals, Inc. | -0.6722 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.074M |
| Total Expenses (Quarterly) | 4.074M |
| Enterprise Value | 8.192M |
| Earnings Yield | -96.91% |
| Normalized Earnings Yield | -96.91 |